Forward Pharma FA ApS: Financial statements 2018
CVR: 37281603
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Forward Pharma FA ApS (CVR 37281603) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -25,125 and a net result of DKK -27,673 compared with DKK -447,221 the year before. Equity in the 2018 report amounted to DKK -56,305.
- Gross Profit
- DKK -25,125
- Profit/Loss
- DKK -27,673
- Equity
- DKK -56,305
- Total Assets
- DKK 738,847
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -25 t. | -28 t. | -56 t. | - |
| 2017 | - | -569 t. | -447 t. | -29 t. | - |
| 2016 | - | -2.2 mio. | -1.7 mio. | 419 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Forward Pharma FA ApS has published its annual report for 2017. Gross profit came to DKK -568,692, and the net result was DKK -447,221.
About Forward Pharma FA ApS
Forward Pharma FA ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2015 and dissolved in 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2022, the company reported a gross profit of DKK -32,125 and a net result of DKK -35,837 compared with DKK -11,447 the year before. Equity in the 2022 report amounted to DKK 39,283.